KIMS Shareholders Approve Material Related Party Transaction with Subsidiary Through Postal Ballot

2 min read     Updated on 03 Feb 2026, 05:39 PM
scanx
Reviewed by
Naman SScanX News Team
Overview

Krishna Institute of Medical Sciences Limited successfully concluded its postal ballot on February 01, 2026, with shareholders approving a material related party transaction with subsidiary KIMS Hospital Bengaluru Private Limited by 93.18% majority. The e-voting process saw participation from 499 shareholders representing 31,85,61,832 shares, with Krishna Rao Inturi of IKR & Associates serving as scrutinizer. The resolution received unanimous support from promoters and strong backing from public shareholders, demonstrating confidence in the proposed transaction.

31666189

*this image is generated using AI for illustrative purposes only.

Krishna Institute of Medical Sciences Limited has announced the successful completion of its postal ballot process, with shareholders overwhelmingly approving a material related party transaction with its subsidiary company. The voting concluded on February 01, 2026, marking a significant milestone in the company's corporate governance processes.

Voting Results and Participation

The postal ballot witnessed strong shareholder participation, with detailed voting statistics reflecting broad-based support for the proposed resolution.

Participation Metrics Details
Total Shareholders Voted 499
Total Shares Represented 31,85,61,832
Voting Period January 03, 2026 to February 01, 2026
Cut-off Date December 30, 2025

Resolution Details and Approval

The single ordinary resolution on the agenda concerned the approval of a material related party transaction with KIMS Hospital Bengaluru Private Limited, a subsidiary company. The voting results demonstrated overwhelming shareholder support across all categories.

Voting Breakdown by Category

Category Shares Held Votes Polled % Polled Votes in Favor Votes Against % in Favor
Promoter and Promoter Group 136489330 110694350 81.10% 110694350 0 100.00%
Public Institutions 188228253 170422524 90.54% 148685944 21736580 87.25%
Public Non-Institutions 75421352 37437477 49.64% 37436493 984 99.99%
Total 400138935 318554351 79.61% 296816787 21737564 93.18%

Scrutinizer's Oversight and Process

Krishna Rao Inturi, Proprietor of IKR & Associates and Practicing Company Secretary, served as the appointed scrutinizer for the postal ballot process. The scrutinizer was appointed by the board of directors through a resolution passed on December 29, 2025, ensuring independent oversight of the voting process.

The e-voting facility was provided by MUFG Intime India Private Limited, with the platform remaining accessible from January 03, 2026, 09:00 AM to February 01, 2026, 05:00 PM. The votes were unblocked on February 02, 2026, in the presence of two independent witnesses who were not employed by the company.

Regulatory Compliance and Documentation

The postal ballot process was conducted in strict accordance with:

  • Sections 108 and 110 of the Companies Act, 2013
  • Rules 20 and 22 of the Companies (Management and Administration) Rules, 2014
  • Regulation 44 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

The voting results and scrutinizer's report have been disclosed to both BSE and NSE, with the company maintaining transparency through uploads on its website www.kimshospitals.com and the e-voting platform. The resolution is deemed to have been passed on February 01, 2026, the last date of e-voting, with the requisite majority achieved as confirmed by the scrutinizer's report dated February 03, 2026.

Historical Stock Returns for Krishna Institute of Medical Sciences

1 Day5 Days1 Month6 Months1 Year5 Years
+3.60%+4.40%+16.28%-5.41%+32.37%+259.82%
Krishna Institute of Medical Sciences
View Company Insights
View All News
like16
dislike

KIMS Revises Q3FY26 Earnings Conference Call to February 9, 2026

1 min read     Updated on 02 Feb 2026, 08:45 PM
scanx
Reviewed by
Shriram SScanX News Team
Overview

Krishna Institute of Medical Sciences Limited has issued a revised intimation changing its Q3FY26 earnings conference call from February 7 to February 9, 2026, at 9:30 AM IST. The call, hosted by IIFL Capital, will feature senior management including Dr. Bhaskara Rao Bollineni, Dr. Abhinay Bollineni, and Mr. Sachin Salvi to discuss financial results and business strategy.

31590919

*this image is generated using AI for illustrative purposes only.

Krishna Institute of Medical Sciences Limited has issued a revised intimation regarding its earnings conference call with analysts and investors to discuss Q3FY26 financial results and business strategy. The healthcare provider updated stock exchanges about the schedule change pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Revised Conference Call Schedule

The earnings conference call has been rescheduled to Monday, February 9, 2026, at 9:30 AM IST, moving from the previously announced date of February 7, 2026. IIFL Capital continues to host the session, providing a platform for management to interact with the investment community following the declaration of Q3FY26 financial results.

Parameter: Details
Date: Monday, February 9, 2026
Time: 9:30 AM IST
Host: IIFL Capital
Purpose: Q3FY26 results discussion and business strategy
Previous Date: Saturday, February 7, 2026
Previous Time: 10:30 AM IST

Management Participation

The conference call will feature the same senior leadership team from Krishna Institute of Medical Sciences, ensuring comprehensive coverage of the company's performance and strategic direction.

Role: Name
Founder & Managing Director: Dr. Bhaskara Rao Bollineni
Executive Director & CEO: Dr. Abhinay Bollineni
Chief Financial Officer: Mr. Sachin Salvi

Access Information

IIFL Capital continues to provide multiple access options for participants across different regions. The call offers both domestic and international dial-in numbers to accommodate global investors, with updated timing for international participants.

India Access Numbers:

  • Universal Access: +91 22 6280 1259 / +91 22 7115 8160

International Toll-Free Numbers:

  • USA: 1-866 746 2133
  • UK: 0-808 101 1573
  • Singapore: 800-101 2045
  • Hong Kong: 800-964 448

International Time Zones:

  • Hong Kong/Singapore: 12:00 PM
  • UK: 4:00 AM
  • USA: 11:00 PM ET

Regulatory Compliance

The company has fulfilled its disclosure obligations by notifying both the Bombay Stock Exchange (BSE) and National Stock Exchange (NSE) about the revised conference call schedule. The updated communication was signed by Nagajayanthi J. R., Company Secretary & Compliance Officer, on February 4, 2026, referencing the earlier intimation dated February 2, 2026.

For additional information regarding the conference call, participants can contact IIFL Capital representatives Rahul Jeewani, Naman Bagrecha, or Vivek Pandey through the provided contact details.

Historical Stock Returns for Krishna Institute of Medical Sciences

1 Day5 Days1 Month6 Months1 Year5 Years
+3.60%+4.40%+16.28%-5.41%+32.37%+259.82%
Krishna Institute of Medical Sciences
View Company Insights
View All News
like19
dislike

More News on Krishna Institute of Medical Sciences

1 Year Returns:+32.37%